Geode Capital Management increased its stake in Corcept Therapeutics, while Morgan Stanley lifted its holdings and Renaissance Technologies trimmed its position.

The entities involved

• Corcept Therapeutics →

  American pharmaceutical company

  • Corcept Therapeutics made required filings with the SEC regarding institutional holdings on June 16, 2026.Mon 03:27
• Geode Capital Management →

  American Investment Management firm based in Boston, Massachusetts

  • Geode Capital Management acquired a new stake in Walmart shares during Q4.Mon 02:10
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• Renaissance Technologies →

  American hedge fund firm

  • Renaissance Technologies holds a significant stake in Lite Strategy, Inc., whose stock trades on the Nasdaq exchange.Sun 19:54
  • A company acquired a new position in Freeport-McMoRan shares, leading to required 13F filings with the SEC on June 6, 2026.Sun 19:14

Related events

• Geode Capital Management increased its stake in Elicio Therapeutics on August 17, 2026.Aug 17
• Geode Capital Management increased its holdings in Aquestive Therapeutics, Inc. on September 12, 2026.Sep 12
• Geode Capital Management increased its stake in Citius Oncology, Inc. on July 24, 2026, with MarketBeat aggregating company performance information.Jul 25
• Geode Capital Management and Renaissance Technologies increased their holdings in DocGo stock, while Cantor Fitzgerald provided rating updates.Aug 12
• Geode Capital Management raised its position in Biofrontera stock on August 30, 2026.Aug 30